company background image
530313 logo

Kimia Biosciences BSE:530313 Stock Report

Last Price

₹46.17

Market Cap

₹2.2b

7D

-7.2%

1Y

28.2%

Updated

15 Feb, 2025

Data

Company Financials

Kimia Biosciences Limited

BSE:530313 Stock Report

Market Cap: ₹2.2b

530313 Stock Overview

Manufactures and sells active pharmaceutical ingredients (APIs) in India. More details

530313 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance3/6
Financial Health2/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Kimia Biosciences Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Kimia Biosciences
Historical stock prices
Current Share Price₹46.17
52 Week High₹58.40
52 Week Low₹34.37
Beta1.04
1 Month Change7.37%
3 Month Change-2.14%
1 Year Change28.18%
3 Year Change9.93%
5 Year Change142.36%
Change since IPO396.45%

Recent News & Updates

Recent updates

Shareholder Returns

530313IN PharmaceuticalsIN Market
7D-7.2%-7.5%-5.6%
1Y28.2%9.0%-0.9%

Return vs Industry: 530313 exceeded the Indian Pharmaceuticals industry which returned 9% over the past year.

Return vs Market: 530313 exceeded the Indian Market which returned -0.9% over the past year.

Price Volatility

Is 530313's price volatile compared to industry and market?
530313 volatility
530313 Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.4%

Stable Share Price: 530313 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 530313's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993250Sameer Goelwww.kimiabiosciences.com

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrintenstinal agents, anti-coagulants, anti-hypertensive, lipid lowering agents, vitamins, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its products.

Kimia Biosciences Limited Fundamentals Summary

How do Kimia Biosciences's earnings and revenue compare to its market cap?
530313 fundamental statistics
Market cap₹2.18b
Earnings (TTM)₹28.94m
Revenue (TTM)₹1.07b

75.5x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530313 income statement (TTM)
Revenue₹1.07b
Cost of Revenue₹684.12m
Gross Profit₹386.12m
Other Expenses₹357.19m
Earnings₹28.94m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

May 30, 2025

Earnings per share (EPS)0.61
Gross Margin36.08%
Net Profit Margin2.70%
Debt/Equity Ratio14,959.0%

How did 530313 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/15 15:15
End of Day Share Price 2025/02/14 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kimia Biosciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.